takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedémy, dědičné - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
celsunax
pinax pharma gmbh - joflupan (123i) - radionuclide imaging; dementia; movement disorders - diagnostické radiofarmaka - tento léčivý přípravek je určen pouze pro diagnostické účely. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. u dospělých pacientů, pomoci odlišit pravděpodobné demence s lewyho tělísky od alzheimerovy choroby. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
diozen 500mg potahovaná tableta
zentiva, k.s., praha array - 21063 mikronizovanÝ diosmin - potahovaná tableta - 500mg - diosmin
diozen forte 1000mg potahovaná tableta
zentiva, k.s., praha array - 21063 mikronizovanÝ diosmin - potahovaná tableta - 1000mg - diosmin
pasorin-ol injekce
bioveta, a.s. - pasteurella vakcíny - injekce - inaktivované bakteriální vakcíny (včetně mycoplasma, toxoid a chlamydie vakcín) - králíci